Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3

Ítems similars

• Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln
  per: Mira Holliday, et al.
  Publicat: (2018-12-01)
• Characterization of the first induced pluripotent stem cell line generated from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia due to a heterozygous mutation in cardiac calsequestrin-2
  per: Samantha Ross, et al.
  Publicat: (2019-05-01)
• Generation of an isogenic CRISPR/Cas9-corrected control induced pluripotent stem cell line from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia with a heterozygous variant in cardiac calsequestrin-2
  per: Ginell N. Ranpura, et al.
  Publicat: (2025-03-01)
• Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
  per: Helms, Adam S., et al.
  Publicat: (2020)
• Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy
  per: Burns, Charlotte, et al.
  Publicat: (2017)